Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Feb 15;127(4):648-649.
doi: 10.1002/cncr.33252. Epub 2020 Oct 29.

Assessing clinical trial effects on outcomes among pediatric and adolescent and young adult (AYA) patients with cancer

Shahar Shmuel  1 , Jeff Y Yang  1 , Sydney Thai  1 , Michael Webster-Clark  1 , Jennifer L Lund  1
Affiliations
Comment

Assessing clinical trial effects on outcomes among pediatric and adolescent and young adult (AYA) patients with cancer

Shahar Shmuel et al. Cancer. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: JLL’s spouse is a full-time, paid employee of and owns stock in GlaxoSmithKline. No potential conflicts of interest were disclosed by the other authors.

Comment in

Comment on

References

    1. Schapira MM, Stevens EM, Sharpe JE, et al. Outcomes among pediatric patients with cancer who are treated on trial versus off trial: A matched cohort study. Cancer. May 2020. doi: 10.1002/cncr.32947 - DOI - PMC - PubMed
    1. Lund MJ, Eliason MT, Haight AE, Ward KC, Young JL, Pentz RD. Racial/ethnic diversity in children’s oncology clinical trials: Ten years later. Cancer. 2009;115(16):3808–3816. doi: 10.1002/cncr.24437 - DOI - PubMed
    1. Bhatia S. Disparities in cancer outcomes: Lessons learned from children with cancer. Pediatr Blood Cancer. 2011;56(6):994–1002. doi: 10.1002/pbc.23078 - DOI - PMC - PubMed
    1. Mittal N, Davidson J, Martinez MF, et al. A Tri-Institutional Approach to Address Disparities in Children’s Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities. J Adolesc Young Adult Oncol. 2019;8(3):227–235. doi: 10.1089/jayao.2018.0119 - DOI - PubMed
    1. Hamel LM, Penner LA, Albrecht TL, Heath E, Gwede CK, Eggly S. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control. 2016;23(4):327–337. doi: 10.1177/107327481602300404 - DOI - PMC - PubMed